Pfizer agreed to a $5.29 billion deal to supply the U.S. its Covid-19 pill to treat 10 million people via WSJ
& Co. and Ridgeback Biotherapeutics LP that is also under review by the FDA. The U.S. has agreed to purchase 3.1 million courses of molnupiraivir for about $2.2 billion.in the treatment of Covid-19. People would take the therapies at home shortly after they first develop symptoms to be able to keep them from becoming hospitalized. Covid-19 antibody therapies cleared for use are largely administered in hospitals and physicians’ offices or given to patients with advanced forms of the disease.
“My administration is making the necessary preparations now to ensure these treatments will be easily accessible and free,” Mr. Biden said. “This is positive news. This treatment could prove to be another critical tool in our arsenal that will accelerate our path out of the pandemic.”
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
COVID-19 live updates: 21 states see at least 10% jump in daily casesNEW: Pfizer has asked the FDA to authorize its COVID-19 pill, the company has announced in a press release. Both Merck and Pfizer are working on pills that appear very effective at keeping patients out of the hospital, according to the companies.
続きを読む »
U.S. expected to purchase 10 million courses of Pfizer COVID-19 pill - WaPoEarlier this month, Pfizer, which also makes one of the mostly widely used COVID-19 vaccines, said the pill https://reut.rs/3oxaxnz cut the chance of hospitalization or death for adults at risk of severe disease by 89% in its clinical trial. Pfizer expects to submit interim trial results for the pill, branded Paxlovid, to the Food and Drug Administration (FDA) before the Nov. 25 U.S. Thanksgiving holiday.
続きを読む »
Pfizer asks US officials to OK promising COVID-19 pillWASHINGTON (AP) — Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the stage for a likely launch of the promising therapy in the coming weeks.
続きを読む »
Pfizer Seeks FDA Emergency Use Authorization for Its COVID-19 PillPfizer has signed a deal to allow other manufacturers to make its experimental COVID-19 pill, possibly opening up access to treatment to countries across the world:
続きを読む »
Pfizer seeks FDA emergency use authorization for its experimental Covid-19 antiviral pillPfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid.
続きを読む »